VDS Conversations: What If Aging Were Not Inevitable? Insights From Aubrey de Grey

VDS is widely known for startups, AI, and scale. But the conversations shaping the intelligent age also include deeper structural challenges in society. At the last edition of VDS, one of the most technical and thought provoking sessions asked a question at the frontier of medicine and biotechnology.

What if aging is not inevitable?

That was the premise of the talk by Dr. Aubrey de Grey, founder and Chief Science Officer of the LEV Foundation, an organization focused on repairing the molecular and cellular damage associated with aging. You can explore the organization and his work here: LEV Foundation and Dr. Aubrey de Grey at LEV Foundation.

 

Why this conversation belongs at VDS

VDS is built around high value business connections, but the international tech event also creates space for ideas that can reshape entire industries, including healthcare. This is part of VDS’s broader positioning as a global meeting point for startups, scaleups, corporates, and investors gathering at the City of Arts and Sciences in Valencia.

 

 

The core idea: aging is accumulated damage

De Grey’s thesis starts with an engineering mindset. Metabolism is the set of processes that keeps us alive, but it also creates ongoing molecular and cellular damage as a byproduct. The body can tolerate some of this damage. Over time, however, damage accumulates until it crosses a threshold, at which point age associated diseases become more likely.

In this framework, many conditions treated as separate diseases are better understood as downstream consequences of a shared root cause: accumulated damage.

Modern medicine is powerful at managing late stage disease, but much of that work happens after damage has built up for decades. De Grey argues that the historical pattern has been to treat age related diseases one by one, rather than addressing the common structural driver behind them. The result is progress, but often in a reactive mode, intervening late instead of maintaining early.

 

Why periodic repair changes the frame

Classic gerontology often focused on slowing aging by changing metabolism so less damage is generated. The problem is complexity. Metabolism is a tightly interconnected system. Modifying it safely, predictably, and at scale without unintended effects is extremely difficult, which is one reason these approaches have not delivered a simple and widely applicable solution.

De Grey proposes a pragmatic strategy. Do not redesign the engine. Maintain it. Instead of trying to stop damage from occurring, the goal is to repair damage periodically, before it becomes severe enough to trigger major pathology. The logic resembles preventive maintenance in engineering: the focus shifts from isolated disease treatment to systemic, repeatable repair.

When De Grey began pushing this framework more than two decades ago, many considered it unrealistic. Since then, advances in biotechnology, regenerative medicine, and cellular therapies have shifted the landscape. Even when experts disagree on timelines, the idea of repair based interventions has moved closer to the mainstream of longevity research.

Longevity is not just a scientific frontier. It is also a platform shift with economic and societal implications. Real progress in damage repair would affect healthcare cost curves, workforce participation, insurance models, diagnostics, therapeutics, and the ethics of access. For innovators, it creates both responsibility and opportunity, with new markets emerging at the intersection of biotech, AI, data, and medicine.

If you want more content that connects frontier science with real world innovation, explore the latest VDS stories and conversations at VDS News.